IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice

Keith L. Knutson, Yushe Dang, Hailing Lu, Jason Lukas, Bond Almand, Ekram Gad, Ehizoje Azeke, Mary L. Disis

Research output: Contribution to journal › Article › peer-review

110 Scopus citations

Fingerprint

Dive into the research topics of 'IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice'. Together they form a unique fingerprint.

Medicine & Life Sciences